Admission characteristics of patients with diffuse interstitial lung disease in a pulmonary rehabilitation program
Características de ingreso de pacientes con enfermedad pulmonar intersticial difusa en un programa de rehabilitación pulmonar
Article Sidebar
PDF (Español (España))
FLIP
COPYRIGHT NOTICE
The authors who publish in the Movimiento Científico Journal agree with the following terms:
1. The authors retain the copyright and guarantee the journal the right to be the first publication of the work, as well as licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgment of authorship , the mixture or remix must be published under the same initial publication license, does not allow commercial exploitation of it.
2. The concepts and opinions expressed in the articles are the sole responsibility of the authors and do not commit the Ibero-American University Corporation. The contents of this magazine are distributed under license: Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.
3. The Movimiento Científico Journal is open access, so that both the editorial process and the published content are available to all users free of charge: the Magazine does not charge for reading or publishing.
Responsibilities. The concepts, opinions and ideas expressed in the published articles are the responsibility of the authors.For purposes of compliance with this point the authors must fill out the Letter of originality, which will be sent along with the article to the magazine's mail.
Main Article Content
Objective: To know the characteristics of admission, diagnosis and treatment of patients with Diffuse Interstitial Lung Disease (DILD) who attend a Pulmonary Rehabilitation program in Cali. Method: It is a descriptive cross-sectional study, patients were included consecutively. Using a structured survey, information on sociodemographic, clinical and dyspnea characteristics was collected. Results: The average age was 58.2 years, 61.5% were men and 69.9% resided in Cali. 73.9% had never smoked. 15.4% had exposure to wood smoke. 23.1% had occupational exposure. 53.8% of patients had exacerbations in the last year. 69.9% require home oxygen. The MRC grade of dyspnea shows that 30.8% of the patients had grade 3 and 4 each; The distance covered in the six-minute walk test shows an average of 309.7 meters. The mean FVC is 58.6%, for FEV1 it is 63.5% and for FEV1/FVC it is 104.1%. Chest radiography confirmed interstitial changes in all 13 patients. Short-acting β2 agonists 46.2% are the most used drugs. Conclusions: The diagnosis of ILD is made through suggestive changes on chest radiology in 90% of cases. Pulmonary rehabilitation is a treatment alternative for symptomatic patients; Family history, prolonged treatment with some medications and autoimmune diseases may allow the disease to be properly classified in future studies.
Downloads
Article Details
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. (2002). ATS statement: guidelines for the six-minute walk test.American Journal of Respiratory and Critical Care Medicine, 166(1), 111. doi: 10.1164/rccm.166/1/111
American Thoracic Society. (2000). Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. doi: 10.1164/rccm.2009-040GL
Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. (1997). Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med; 155: 242-8.
Baumgartner, K. B., Samet, J. M., Coultas, D. B., Stidley, C. A., Hunt, W. C., Colby, T. V., ... & Centers, C. (2000). Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. American journal of epidemiology, 152(4), 307-315. doi: 10.1093/aje/152.4.307
Chapman J, Faver C. (2004). Idiopathic interstitial lung disease: a review of recent classifications. Clin Pulm Med; 11.
Daniels CE, Ryu JH. (2006). Treatment of idiopathic pulmonary fibrosis. Semin Respir Crit Care Med; 27: 668-76. doi: 10.1055/s-2006-957338
De Vries, J., & Drent, M. (2006). Quality of life and health status in interstitial lung diseases. Current opinion in pulmonary medicine, 12(5), 354-358. doi: 10.1097/01.mcp.0000239553.93443.d8
Dowman, L., McDonald, C. F., Hill, C., Lee, A., Barker, K., Boote, C., ... Burge, A. (2013). The benefits of exercise training in interstitial lung disease: protocol for a multicentre randomised controlled trial. BMC pulmonary medicine, 13(1), 8. doi:10.1186/1471-2466-13-8
Dueñas, C., Londoño, A., Manzano, A. C., & Ojeda, P. (1991). Enfermedad pulmonar intersticial difusa (EPID). Acta médica Colombiana, 16(3). Recuperado de http://www.actamedicacolombiana.com/
Ekström, M., Gustafson, T., Boman, K., Nilsson, K., Tornling, G., Murgia, N., & Torén, K. (2014). Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study. BMJ open, 4(1), e004018. doi:10.1136/bmjopen-2013-004018
European, R. S., & Society, A. T. (2002). American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.
This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. American journal of respiratory and critical care medicine, 165(2), 277. Recuperado de www.atsjournals.org
Fernández, D. I., Sánchez, R. P., Moreno, A. F., & Fabrellas, E. F. (2009). Aspectos relevantes en el manejo de la enfermedad pulmonar intersticial difusa. Archivos de Bronconeumología, 45, 3-8. Recuperado
de www.archbronconeumol.org
Ferreira, A., Garvey, C., Connors, G. L., Hilling, L., Rigler, J., Farrell, S., ... Collard, H. R. (2009). Pulmonary Rehabilitation in Interstitial Lung Disease Benefits and Predictors of Response. CHEST Journal, 135(2), 442-447. doi:10.1378/chest.08-1458
Fletcher, C. (1960). Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ, 2, 1665.
Hansell A, Hollowell J, Nichols T, McNiece R, Strachan D. (1999). Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax; 54: 413-9. doi:10.1136/thx.54.5.413
Holland, A. E., Hill, C. J., Conron, M., Munro, P., & McDonald, C. F. (2008). Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax, 63(6), 549-554. doi:10.1136/thx.2007.088070
Jaramillo, M., Núñez, M., Ocampo, W., Pérez, D., & Portilla, G. (2004). Inventario de emisiones de contaminantes atmosféricos convencionales en la zona de Cali-Yumbo. Revista Facultad de Ingeniería Universidad de Antioquia, 31, 38-48.
Kaymaz, D., Ergün, P., Candemir, I., Utku, E., Demir, N., Sengül, F., . . . Demir, P. (2013). Pulmonary rehabilitation in interstitial lung diseases. Tüberküloz ve toraks, 61(4), 295. doi:10.5578/tt.6291
Lederer, D. J., Arcasoy, S. M., Wilt, J. S., D’Ovidio, F., Sonett, J. R., & Kawut, S. M. (2006). Six minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine, 174(6), 659-664. doi:0.1164/rccm.200604-520OC
Lopez Campos JL, Rodríguez Becerra E, on behalf of the NEUMOSUR Task Group. (2004). Registry of interstitial lung diseases. Incidence of interstitial lung diseases, in the south of spain 1998-2000: The REINA study. Eur J Epidemiol; 19: 155-61. doi: 10.1023/B:EJ EP.0 000017660.18541.83
Manresa, J., Sena, F., & Caballol, R. (2001). El control de la oxigenoterapia domiciliaria en un hospital comarcal. Archivos de Bronconeumología, 37(7), 237-240. Recuperado de www.archbronconeumol.org
Nici, L., Donner, C., Wouters, E., Zuwallack, R., Ambrosino, N., Bourbeau, J., ... Fahy, B. (2006). American thoracic society/European respiratory society statement on pulmonary rehabilitation. American journal of respiratory and critical care medicine, 173(12), 1390-1413. doi: 10.1164/rccm.200508-1211ST
Nishiyama, O., Kondoh, Y., Kimura, T., Kato, K., Kataoka, K., Ogawa, T., ... Taniguchi, H. (2008). Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology, 13(3), 394-399. doi: 10.1111/j.1440-1843.2007.01205.x
Du Bois, R. M., & Richeldi, L. (Eds.). (2009). European Respiratory Monograph 46: Interstitial Lung Diseases (Vol. 46). European Respiratory Society.
Raghu G. (2011). Interstitial lung disease. In: Goldman L, Schafer AI, eds.Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders:chap 92.
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., ... Lasky, J. A. (2011). An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines
for diagnosis and management. American Journal of Respiratory and Critical Care Medicine, 183(6), 788-824. doi: 10.1164/rccm.2009-040GL
Ries, A. L. (2008). Pulmonary rehabilitation: summary of an evidence-based guideline. Respiratory care, 53(9), 1203-1207. Recuperado de http://rc.rcjournal.com/
Salhi, B., Troosters, T., Behaegel, M., Joos, G., & Derom, E. (2010). Effects of pulmonary rehabilitation in patients with restrictive lung diseases. CHEST Journal, 137(2), 273-279. doi:10.1378/chest.09-0241
Spagnolo, P., Tonelli, R., Cocconcelli, E., Stefani, A., & Richeldi, L. (2012). Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. Multidisciplinary respiratory medicine, 7(1),
doi:10.1186/2049-6958-7-42
Schwarz MI y King TE Jr. (1993). Interstitial lung disease, 2nd ed, Mosbyyear book Inc, Philadelphia.
Tapia, R., Andrade, C., & González, H. (2006). Enfermedad pulmonar intersticial difusa: revisión. REVISTA CHILENA DE MEDICINA INTENSIVA, 21(2), 87-96.
Vélez A, H., Rojas, W., Borrero R, J., & Restrepo M, J. (2007). Fundamentos de medicina: Neumología.
